Neoplasms Metastasis Terminated Phase 2 Trials for Bevacizumab (DB00112)

Also known as: Neoplasm Metastasis / Metastasis, Neoplasm

IndicationStatusPhase
DBCOND0066909 (Neoplasms Metastasis)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00120172Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal CancerTreatment
NCT00281528Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast CancerTreatment